You are here: Home » News-CM » Companies » News
Business Standard

Natco Pharma receives EIR for its Vizag facility

Topics
Health Medical Pharma

Capital Market 

Natco Pharma announced the successful closure and receipt of an Establishment Inspection Report (EIR) from the U.

S. Food and Drug Administration (USFDA) for its drug formulations manufacturing facility at Visakhapatnam (Vizag), Andhra Pradesh, India, for an inspection conducted during the period from 24 March to 30 March, 2020.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, May 20 2020. 16:04 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU